Slagle Financial, LLC

Position in PFE — Pfizer Inc

CIK 1984918 Edwardsville, IL

Position in PFE

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$221,174

-$2,138,697 QoQ

Shares Held

9,185

-89.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#2,382

of 2,821 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Slagle Financial, LLC holds $9,819,740 across 7 Drug Manufacturers - General names. PFE ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	16,066	$4,080,282
2	AMGN	Amgen Inc	9,098	$3,294,567
3	ABBV	AbbVie Inc.	5,092	$1,281,350
4	LLY	ELI LILLY & Co	413	$495,364
5	MRK	Merck & Co., Inc.	1,761	$226,288
6	PFE	Pfizer Inc This page	9,185	$221,174
7	GILD	Gilead Sciences, Inc.	1,747	$220,715

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$221,174	9,185	-89.1%	Shares	Sole	2026-07-29
2026-03-31	$2,359,871	84,041	+3.7%	Shares	Sole	2026-05-01
2025-12-31	$2,017,945	81,042	+0.9%	Shares	Sole	2026-01-26
2025-09-30	$2,045,763	80,289	+3.1%	Shares	Sole	2025-11-06
2025-06-30	$1,886,817	77,839	+4.1%	Shares	Sole	2025-08-11
2025-03-31	$1,894,114	74,748	+1.5%	Shares	Sole	2025-04-30
2024-12-31	$1,953,350	73,628	+6.1%	Shares	Sole	2025-02-12
2024-09-30	$2,007,394	69,364	+8.0%	Shares	Sole	2024-10-31
2024-06-30	$1,796,959	64,223	+7.4%	Shares	Sole	2024-07-24
2024-03-31	$1,658,895	59,780	-43.0%	Shares	Sole	2024-05-16
2023-12-31	$3,021,452	104,948	+102.3%	Shares	Sole	2024-03-05
2023-09-30	$1,720,859	51,880	+5.2%	Shares	Sole	2023-11-14
2023-06-30	$1,808,324	49,300	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.